11.86
02-五月-25 15:45:00
15 分钟延时
股票
-0.13
-1.08%
今日范围
11.80 - 12.47
ISIN
N/A
来源
NASDAQ
Dyne Therapeutics Myotonic Dystrophy Type 1 Program Achieves Robust RNA Knock Down of Toxic Human Nuclear DMPK in Preclinical Study
10 1月 2021 14:00:00 条件 Nasdaq GlobeNewswire
Dyne Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference
05 1月 2021 06:30:00 条件 Nasdaq GlobeNewswire